Science Sun Pharm's subsidiary has received the clinical trial approval notice for the drug
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Science Sun Pharm announced that its subsidiary Shenyang Junyuan Pharmaceutical Co., Ltd. has received the "Drug Clinical Trial Approval Notice" from the National Medical Products Administration, agreeing to conduct clinical trials for the treatment of mammary hyperplasia, with the drug name being Danxiang Granules
According to the Zhitong Finance APP, Science Sun Pharm (300485.SZ) announced that its subsidiary Shenyang Junyuan Pharmaceutical Co., Ltd. has received the "Drug Clinical Trial Approval Notice" from the National Medical Products Administration, agreeing to conduct clinical trials for the treatment of mammary hyperplasia, with the drug name being Danxiang Granules